FORM 8-K

Company

Eton Pharmaceuticals, Inc.

Filed

October 3, 2024

Period of Report

October 2, 2024

Accession Number

0001437749-24-030557

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →